The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab

The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab

Nobuki Furubayashi,1 Akinori Minato,2 Takahito Negishi,1 Naotaka Sakamoto,3 Yoohyun Song,4 Yoshifumi Hori,5 Toshihisa Tomoda,6 Shingo Tamura,7 Kentaro Kuroiwa,5 Narihito Seki,4 Naohiro Fujimoto,2 Motonobu Nakamura1 1Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka,...

Full description

Bibliographic Details
Main Authors: Furubayashi N, Minato A, Negishi T, Sakamoto N, Song Y, Hori Y, Tomoda T, Tamura S, Kuroiwa K, Seki N, Fujimoto N, Nakamura M
Format: Article
Language:English
Published: Dove Medical Press 2021-10-01
Series:Cancer Management and Research
Subjects:
urothelial carcinoma pembrolizumab eosinophil neutrophil-to-eosinophil ratio
Online Access:https://www.dovepress.com/the-association-of-clinical-outcomes-with-posttreatment-changes-in-the-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/the-association-of-clinical-outcomes-with-posttreatment-changes-in-the-peer-reviewed-fulltext-article-CMAR

Similar Items